RFK Jr. unilaterally gives the OK for some unapproved peptides.
Oh boy. This move refers to BPC-157, TB-500, Mots-C, KPV, epitalon, and semax. A document outlining the decision indicates that this seems to be the Health Secretary’s call, even though FDA scientists advised against it in July. This broadens access, but still requires a patient-specific prescription and adverse reporting. [Link: Kennedy to Allow Broad Use of Unapproved Peptide Injections | https://www.nytimes.com/2026/10/28/health/peptides-kennedy-fda.html | nytimes.com]
1
Read